An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

February 29, 2004

Conditions
Sexual Dysfunctions, PsychologicalSexual Arousal Disorder
Interventions
DRUG

sildenafil

sildenafil 50 mg (starting dose) tablet by mouth taken as needed 1 hour before anticipated sexual activity; the dose could be increased to 100 mg or decreased to 25 mg; the duration of therapy in this open-label study was 52 weeks

Trial Locations (82)

10021

Pfizer Investigational Site, New York

10603

Pfizer Investigational Site, White Plains

12601

Pfizer Investigational Site, Poughkeepsie

14609

Pfizer Investigational Site, Rochester

19106

Pfizer Investigational Site, Philadelphia

19148

Pfizer Investigational Site, Philadelphia

19560

Pfizer Investigational Site, Temple

19606

Pfizer Investigational Site, Reading

20770

Pfizer Investigational Site, Greenbelt

22903

Pfizer Investigational Site, Charlottesville

23294

Pfizer Investigational Site, Richmond

27103

Pfizer Investigational Site, Winston-Salem

29621

Pfizer Investigational Site, Anderson

30060

Pfizer Investigational Site, Marietta

30309

Pfizer Investigational Site, Atlanta

30342

Pfizer Investigational Site, Atlanta

31405

Pfizer Investigational Site, Savannah

33028

Pfizer Investigational Site, Pembroke Pines

33180

Pfizer Investigational Site, Aventura

33186

Pfizer Investigational Site, Miami

33324

Pfizer Investigational Site, Plantation

33409

Pfizer Investigational Site, West Palm Beach

33710

Pfizer Investigational Site, St. Petersburg

34614

Pfizer Investigational Site, Brooksville

34652

Pfizer Investigational Site, New Port Richey

34683

Pfizer Investigational Site, Palm Harbor

34957

Pfizer Investigational Site, Jensen Beach

34994

Pfizer Investigational Site, Stuart

34996

Pfizer Investigational Site, Stuart

35801

Pfizer Investigational Site, Huntsville

38119

Pfizer Investigational Site, Memphis

41017

Pfizer Investigational Site, Crestview Hills

41042

Pfizer Investigational Site, Florence

46825

Pfizer Investigational Site, Fort Wayne

47630

Pfizer Investigational Site, Newburgh

47714

Pfizer Investigational Site, Evansville

48034

Pfizer Investigational Site, Southfield

49009

Pfizer Investigational Site, Kalamazoo

53209

Pfizer Investigational Site, Milwaukee

63141

Pfizer Investigational Site, Creve Coeur

66211

Pfizer Investigational Site, Leawood

70002

Pfizer Investigational Site, Metairie

72401

Pfizer Investigational Site, Jonesboro

75231

Pfizer Investigational Site, Dallas

77024

Pfizer Investigational Site, Houston

78705

Pfizer Investigational Site, Austin

78758

Pfizer Investigational Site, Austin

80012

Pfizer Investigational Site, Aurora

82001

Pfizer Investigational Site, Cheyenne

83702

Pfizer Investigational Site, Boise

83712

Pfizer Investigational Site, Boise

84070

Pfizer Investigational Site, Sandy City

85712

Pfizer Investigational Site, Tucson

85719

Pfizer Investigational Site, Tucson

89014

Pfizer Investigational Site, Henderson

89030

Pfizer Investigational Site, North Las Vegas

90210

Pfizer Investigational Site, Beverly Hills

90212

Pfizer Investigational Site, Beverly Hills

90254

Pfizer Investigational Site, Hermosa Beach

90404

Pfizer Investigational Site, Santa Monica

90505

Pfizer Investigational Site, Torrance

91506

Pfizer Investigational Site, Burbank

92103

Pfizer Investigational Site, San Diego

92108

Pfizer Investigational Site, San Diego

94612

Pfizer Investigational Site, Oakland

94705

Pfizer Investigational Site, Berkeley

94706

Pfizer Investigational Site, Albany

95628

Pfizer Investigational Site, Fair Oaks

98055

Pfizer Investigational Site, Renton

98105

Pfizer Investigational Site, Seattle

98115

Pfizer Investigational Site, Seattle

99502

Pfizer Investigational Site, Anchorage

99508

Pfizer Investigational Site, Anchorage

06518

Pfizer Investigational Site, Hamden

06320

Pfizer Investigational Site, New London

06708

Pfizer Investigational Site, Waterbury

08903

Pfizer Investigational Site, New Brunswick

44122-5402

Pfizer Investigational Site, Beachwood

45267-0559

Pfizer Investigational Site, Cincinnati

19607-1649

Pfizer Investigational Site, Reading

19611-1499

Pfizer Investigational Site, West Reading

02904

Pfizer Investigational Site, Providence

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00746967 - An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder | Biotech Hunter | Biotech Hunter